Concept Life Sciences

Bradford, United Kingdom Founded: 2006 • Age: 20 yrs Acquired By Concept Life Sciences
Concept Life Sciences is engaged in drug discovery and development services.

About Concept Life Sciences

Concept Life Sciences is a Healthcare company based in Bradford (United Kingdom) founded in 2006, and was acquired by Concept Life Sciences in October 2015. Concept Life Sciences is engaged in drug discovery and development services. It operates on a Professional Services and Managed Services model. Concept Life Sciences offers products and services including Integrated Drug Discovery, ADMET & DMPK, Biology Services, Chemistry Services, and Toxicology Services. Its focus areas include Biotechnology, Drug Discovery, Pharmaceuticals and Drug Development. Its competitors include Alderley Analytical and Lightcast Discovery; 2 of its 2 listed competitors have raised funding.

Company details

Concept Life Sciences is involved in providing integrated drug discovery and development services. Expertise is offered in chemistry, biology, ADMET, DMPK, and toxicology. Solutions are tailored for therapeutic areas like oncology, neuroscience, and immuno-oncology. Various modalities including small molecules, cell therapies, and antibody drug conjugates are supported. Operations span multiple locations in the United Kingdom, serving pharmaceutical and biotech sectors with specialized research and analytical services.

  • Headquarters Bradford, United Kingdom
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website agenda1.co.uk
  • Social LinkedIn X
  • Acquired by Concept Life Sciences (Oct 2015)
  • Legal Name Concept Life Sciences
Key Metrics

Products & Services of Concept Life Sciences

Concept Life Sciences offers a comprehensive portfolio of products and services, including Integrated Drug Discovery, ADMET & DMPK, Biology Services, Chemistry Services, and Toxicology Services.

Integrated Drug Discovery
Drug Development

Services for drug discovery from target to candidate are provided.

ADMET & DMPK
Pharmacokinetics

In vitro and in vivo assays for drug metabolism are conducted.

Biology Services
Research

Assay development and cellular screening services are offered.

Chemistry Services
Research

Synthetic and medicinal chemistry solutions are provided for clients.

Toxicology Services
Safety Assessment

Toxicity testing including cardiotoxicity and hepatotoxicity is performed.

Investors in Concept Life Sciences

Concept Life Sciences has secured backing from 1 investor. Prominent investors backing the company include Concept Life Sciences.

All
InvestorDescriptionFounded YearDomainLocation
International laboratory testing and consultancy in life sciences are offered.
2014conceptlifesciences.comManchester, United Kingdom
Premium access

Investor details for Concept Life Sciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Concept Life Sciences

2 dated milestones of Concept Life Sciences across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Concept Life Sciences is founded.
  2. Exit Acquired by Concept Life Sciences.

Competitors of Concept Life Sciences

Concept Life Sciences has 2 listed competitors in our database, 2 of them funded. They include Alderley Analytical and Lightcast Discovery.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
alderleyanalytical.com2013Stockport, United Kingdom$869,35241
Bioanalytical assays for drug development are developed and validated.
lightcast.bio2019Cambridge, United Kingdom$107.09M25
Advanced single-cell analysis solutions are provided for biotechnology research.
Premium access

Detailed competitors of Concept Life Sciences

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Concept Life Sciences

Concept Life Sciences was founded in 2006.

Concept Life Sciences is headquartered in Bradford, United Kingdom. It is registered at Bradford, West Yorkshire, United Kingdom.

Concept Life Sciences is involved in providing integrated drug discovery and development services. Expertise is offered in chemistry, biology, ADMET, DMPK, and toxicology. Solutions are tailored for therapeutic areas like oncology, neuroscience, and immuno-oncology. Various modalities including small molecules, cell therapies, and antibody drug conjugates are supported. Operations span multiple locations in the United Kingdom, serving pharmaceutical and biotech sectors with specialized research and analytical services.

Concept Life Sciences's top competitors include Alderley Analytical and Lightcast Discovery.

Concept Life Sciences offers Integrated Drug Discovery, ADMET & DMPK, Biology Services, Chemistry Services, and Toxicology Services.

Concept Life Sciences has 1 investor. Key investors include Concept Life Sciences.

Concept Life Sciences operates through Concept Life Sciences.

Yes. Concept Life Sciences was acquired by Concept Life Sciences in October 2015.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available